Active	Status	Sponsor type	Region	Phase	Filter
2 Active 4 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Chang, Jianhua
NCT04993391: AP-L1898 Capsule in Patients With Non-small Cell Lung Cancer	Recruiting	1/2	156	RoW	JS111(AP-L1898 Capsules)	Suzhou Junjing BioSciences Co., Ltd.	Lung Cancer	06/24	08/24
FS-CY1502-Ph1-01, NCT03944499: Phase 1 Study of FS-1502 in Patients With HER2 Expressed Advanced Solid Tumors and Breast Cancer.	Active, not recruiting	1	297	RoW	FS-1502	Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.	Solid Tumor, Breast Cancer	04/24	06/25

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Chang, Jianhua
NCT04993391: AP-L1898 Capsule in Patients With Non-small Cell Lung Cancer	Recruiting	1/2	156	RoW	JS111(AP-L1898 Capsules)	Suzhou Junjing BioSciences Co., Ltd.	Lung Cancer	06/24	08/24
FS-CY1502-Ph1-01, NCT03944499: Phase 1 Study of FS-1502 in Patients With HER2 Expressed Advanced Solid Tumors and Breast Cancer.	Active, not recruiting	1	297	RoW	FS-1502	Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.	Solid Tumor, Breast Cancer	04/24	06/25